Investor Conference Call

FY/Q4 2019 Results

Thursday, February 27, 2020
Start at approx. 2:00 p.m. CET (1:00 p.m. UTC)

Investor News February 27, 2020

Fiscal 2019:

Bayer strategically and operationally successful

Group sales advance by 3.5 percent (Fx & portfolio adj.) to 43.545 billion euros / EBITDA before special items increases by 28.3 percent to 11.503 billion euros / Core earnings per share up by 14.3 percent to 6.40 euros / Net income rises 141.4 percent to 4.091 billion euros - gain of 1.637 billion euros on sale of Currenta stake / Free cash flow of 4.214 billion euros above expectations / Proposed dividend of 2.80 euros per share / Crop Science shows solid performance in challenging environment, substantial increase in earnings due to acquired business / Pharmaceuticals shows encouraging business development / Sales growth at Consumer Health, earnings at prior-year level despite divestments / Ongoing portfolio, structural and efficiency measures implemented successfully / Glyphosate's positive safety profile confirmed - appeal and mediation proceedings moving forward / Outlook for 2020: increase in sales, earnings and free cash flow / Ambitious sustainability targets set MORE



Werner Baumann
CEO of
Bayer AG

Audio recording of the investor conference call (including slides)


Audio file

You can also play the audio recording on your mobile device.


Presentation charts

Q4 2019 Analyst and Investor Briefing


Wolfgang Nickl
CFO of
Bayer AG

2019 Annual Report


FY/Q4 2019 All in One Package for Investors and Analysts